Applied Therapeutics partners with Advanz Pharma for commercialization of Govorestat in Europe
Advanz Pharma will leverage its specialty, hospital, and rare disease expertise and infrastructure to commercialize AT-007 in Europe for both Galactosemia and SORD Deficiency